News & Updates

Norfloxacin prevents bacterial infections in patients with liver failure

10 May 2022 by

Primary norfloxacin prophylaxis is both safe and effective in preventing bacterial infections in patients with acute-on-chronic liver failure (ACLF), a study has shown.

Norfloxacin prevents bacterial infections in patients with liver failure

10 May 2022

Rectal evacuation disorders tied to poor bowel preparation in chronic constipation patients

10 May 2022

Outlet dysfunction is associated with suboptimal bowel preparation and decreased cecal intubation, among others, in patients with chronic constipation undergoing colonoscopy, reveals a study.

Rectal evacuation disorders tied to poor bowel preparation in chronic constipation patients

10 May 2022

Adebrelimab plus chemo almost doubles OS, triples PFS in extensive-stage SCLC

06 May 2022 by

Adding adebrelimab to chemotherapy improves survival outcomes over chemotherapy alone in patients with extensive-stage small cell lung cancer (SCLC) in the phase III CAPSTONE-1 study presented at AACR 2022. This brings hope to SCLC patients with limited treatment options and poor prognoses.

Adebrelimab plus chemo almost doubles OS, triples PFS in extensive-stage SCLC

06 May 2022

Viruses causing gastroenteritis in children thrive in stools of asymptomatic carriers

05 May 2022

The stools of asymptomatic patients carry the most common viruses that cause gastroenteritis in children and serve as a potential reservoir for acute gastroenteritis (AGE), a study has shown.

Viruses causing gastroenteritis in children thrive in stools of asymptomatic carriers

05 May 2022

Original New Drug Application Approvals by US FDA (16 - 30 April 2022)

05 May 2022

New drug applications approved by US FDA as of 16-30 April 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 30 April 2022)

05 May 2022

Guselkumab promising for Crohn’s disease

28 Apr 2022

In Crohn’s disease patients with inadequate response or intolerance to conventional or biologic therapy, guselkumab, a selective p19 interleukin (IL)-23 antagonist, appears effective by yielding better clinical and endoscopic improvements than placebo, a recent study has found.

Guselkumab promising for Crohn’s disease

28 Apr 2022

Hypertriglyceridemia tied with severe acute pancreatitis

27 Apr 2022

The risk of severe acute pancreatitis appears to be significantly and independently associated with hypertriglyceridemia, reports a recent study.

Hypertriglyceridemia tied with severe acute pancreatitis

27 Apr 2022

Whole grain vs refined wheat foods do not differ in glycaemic response, gastric emptying

21 Apr 2022

Whole grain wheat foods boast of several health benefits but, in their natural composition, do not provide lower postprandial glycaemia or gastric emptying relative to their refined wheat counterparts, reveals a recent study.

Whole grain vs refined wheat foods do not differ in glycaemic response, gastric emptying

21 Apr 2022

Faecal microbiota transplant safe, effective for recurrent CDI

21 Apr 2022

Faecal microbiota transplantation (FMT) may be an effective intervention for recurrent Clostridioides difficile infection (CDI), leading to high clinical cure and low complication rates, reports a new real-world study.

Faecal microbiota transplant safe, effective for recurrent CDI

21 Apr 2022

Treatment strategies, clinical variables predict relapse in paediatric CD

19 Apr 2022

The past decade has seen a decline in clinical relapses of paediatric luminal Crohn’s disease (CD), according to a study. Relapse risk is associated with clinical, endoscopic, histological, and laboratory variables and treatment strategies.

Treatment strategies, clinical variables predict relapse in paediatric CD

19 Apr 2022

News & Updates

Filter by Specialty:

Specialty:

Norfloxacin prevents bacterial infections in patients with liver failure

Norfloxacin prevents bacterial infections in patients with liver failure

Rectal evacuation disorders tied to poor bowel preparation in chronic constipation patients

Rectal evacuation disorders tied to poor bowel preparation in chronic constipation patients

Adebrelimab plus chemo almost doubles OS, triples PFS in extensive-stage SCLC

Adebrelimab plus chemo almost doubles OS, triples PFS in extensive-stage SCLC

Viruses causing gastroenteritis in children thrive in stools of asymptomatic carriers

Viruses causing gastroenteritis in children thrive in stools of asymptomatic carriers

Original New Drug Application Approvals by US FDA (16 - 30 April 2022)

Original New Drug Application Approvals by US FDA (16 - 30 April 2022)

Guselkumab promising for Crohn’s disease

Guselkumab promising for Crohn’s disease

Hypertriglyceridemia tied with severe acute pancreatitis

Hypertriglyceridemia tied with severe acute pancreatitis

Whole grain vs refined wheat foods do not differ in glycaemic response, gastric emptying

Whole grain vs refined wheat foods do not differ in glycaemic response, gastric emptying

Faecal microbiota transplant safe, effective for recurrent CDI

Faecal microbiota transplant safe, effective for recurrent CDI

Treatment strategies, clinical variables predict relapse in paediatric CD

Treatment strategies, clinical variables predict relapse in paediatric CD